Immunotherapy Drugs Market Size Study, by Type of Drugs (Monoclonal Antibodies, Adult Vaccines, Checkpoint Inhibitors, Interferons Alpha & Beta, Interleukins, Others) by Therapy Area (Cancer, Autoimmune & Inflammatory Diseases, Infectious Diseases, Others) by End-Use (Hospitals, Clinics, Others)- Global opportunity Analysis and Industry Forecast 2019-2025


Global Immunotherapy Drugs Industry valued approximately USD 108.5 billion in 2016 is anticipated to grow with a healthy growth rate of more than 14.0% over the forecast period 2019-2025. Faster drug approval processes, rising prevalence of life style-oriented diseases, and rising adoption of targeted therapies are the primary growth drivers for global immunotherapy drugs Industry. However, the Industry growth is restricted by the high cost of immunotherapy treatment.

Global Immunotherapy Industry is segmented by type of drugs, therapy area and end-use. Based on therapy area the Industry is segmented into cancer, autoimmune & inflammatory diseases, infectious diseases, and others. Among these, currently the Industry is dominated by cancer segment which is anticipated to account for 33% revenue share in 2016. The cancer segment will continue to dominate over the forecast period and is also anticipated to register the highest growth over the forecast period. Increasing prevalence of cancer and rising adoption of immunotherapy for cancer treatment is driving the Industry growth.

The objective of the study is to define Industry sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the Industry. Additionally, the report shall also incorporate available opportunities in micro Industrys for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players.

Immunotherapy Drugs Industry Share and Size by 2019-2025
Immunotherapy Drugs Market Segmentation:
By Type of Drugs:
* Monoclonal Antibodies
* Adult Vaccines
- Preventive Vaccines
- Therapeutic Vaccines
* Checkpoint Inhibitors
* Interferons Alpha & Beta
* Interleukins
* Other Drugs

By Therapy Area:
* Cancer
* Autoimmune & Inflammatory Diseases
* Infectious Diseases
* Other Therapy Area

By End-Use:
* Hospitals
* Clinics
* Other End Users

By Region
* North America
- Canada
* Europe
- Germany
- U.K.
- France
- Italy
- Rest of Europe
- China
- India
- Japan
- Rest of Asia-Pacific
* RoW
- Latin America
- Middle East & Africa

Major Market Players in Immunotherapy Drugs Market are as follows:
Merck & Co., Inc.
Novartis International AG
Johnson & Johnson (A Parent Company of Jannssen Biotech, Inc.)
Glaxosmithkline PLC
Amgen Inc.
Bristol-Mysers Squibb
ELI Lilly & Company

License Type

Find About Us

Contact Us

USA Address

7309 Woodward Ave, Apt 107, Woodridge, Illinois, USA, 60517

Operational & Marketing Center

Global Reports Store Pune (India) Manjari(bk), Hadapsar, Pune 412307


Copyright © 2020 Global Reports Store All rights reserved.